Tixagevimab Completed Phase 3 Trials for Coronavirus Disease 2019 (COVID‑19) Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT05321394Non-inferiority Trial on Treatments in Early COVID-19
NCT04501978ACTIV-3: Therapeutics for Inpatients With COVID-19
NCT04723394Phase III Study of AZD7442 for Treatment of COVID-19 in Outpatient Adults